IL6R and head and neck squamous cell carcinoma: Following treatment with an IL-6R blocker or an ERK inhibitor, there was a clear reversal in the enhanced migration and invasion abilities of all RR HNSCC cell lines (Figure 7E,F and Figure S7C,D).